This constitutive high motility was largely due to autocrine secretion of Hsp90α by the cells, since the addition of neutralizing anti-Hsp90α antibody, 1G6-D7, to the assay prevented the tumour cell motility (panel c vs. panel a). Here, HSP90AA1 is linked to neoplasm.